NorthEast BioLab

Executive Summary

NorthEast BioLab is a well-established contract research organization (CRO) based in Beverly, Massachusetts, with over 20 years of experience in GLP-compliant bioanalytical services. The company specializes in method development, validation, and sample analysis for pharmacokinetics, immunogenicity, biomarkers, and cytokines, supporting small molecules, biologics, and cell/gene therapies through preclinical and clinical stages. With a focus on quality and regulatory compliance, NorthEast BioLab serves as a reliable partner for drug developers seeking comprehensive bioanalytical support. The company's long track record and niche expertise position it favorably in the competitive CRO market, though its private status limits visibility on financial performance and growth initiatives. The diagnostic and proteomics focus aligns with industry trends, but the absence of disclosed recent funding or major contracts suggests a steady, low-profile operation.

Upcoming Catalysts (preview)

• Q4 2026Expansion into cell and gene therapy bioanalysis60% success
• TBDStrategic partnership with a top 20 pharma for biomarker analysis50% success
• Q1 2027Release of new service line for multi-omic integration45% success